OSPHOS

Welcome to the Brand page for “OSPHOS”, which is offered here for Pharmaceutical and veterinary preparations, navicular inflammation drugs, [ osteoporosis drugs, ] osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]; medicines for veterinary purposes, navicular inflammation drugs, osteoporosis drugs, osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ];.

Its status is currently believed to be active. Its class is unavailable. “OSPHOS” is believed to be currently owned by “DECHRA LIMITED”.


Owner:
DECHRA LIMITED
Owner Details
Description:
Pharmaceutical and veterinary preparations, navicular inflammation drugs, [ osteoporosis drugs, ] osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]; medicines for veterinary purposes, navicular inflammation drugs, osteoporosis drugs, osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ];
Categories: PHARMACEUTICAL VETERINARY PREPARATIONS